Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
1 | 39853633 | 0 | Konecki C, Lipman ML, Mavrakanas TA, et al. Population Pharmacokinetic Modelling of Apixaban in End-Stage Kidney Disease Patients with Atrial Fibrillation Receiving Haemodialysis. Clin Pharmacokinet. 2025 Feb;64(2):307-321. doi: 10.1007/s40262-025-01476-6. Epub 2025 Jan 24. |
2 | 39495569 | 0 | Harel Z, Smyth B, Badve SV, et al. Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial. J Am Soc Nephrol. 2024 Nov 4. doi: 10.1681/ASN.0000000000000495. |
3 | 38939758 | 0 | AlTurki A, Marafi M, Dawas A, et al. Meta-analysis evaluating apixaban in patients with atrial fibrillation and end-stage renal disease requiring dialysis. J Arrhythm. 2024 May 6;40(3):440-447. doi: 10.1002/joa3.13051. eCollection 2024 Jun. |
4 | 38744617 | 0 | Wing SM, Mavrakanas TA, Harel Z. Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review. Semin Nephrol. 2024 May 14:151517. doi: 10.1016/j.semnephrol.2024.151517. |
5 | 38272779 | 0 | Ades M, Simard C, Vanassche T, et al. Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease. Semin Nephrol. 2023 Nov;43(6):151484. doi: 10.1016/j.semnephrol.2023.151484. Epub 2024 Jan 24. |
6 | 38035566 | 0 | Elenjickal EJ, Travlos CK, Marques P, et al. Anticoagulation in Patients with Chronic Kidney Disease. Am J Nephrol. 2024;55(2):146-164. doi: 10.1159/000535546. Epub 2023 Nov 30. |
7 | 37768893 | 0 | Festa MC, Rasasingam S, Sharma A, et al. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis. Kidney360. 2023 Sep 1;4(9):e1245-e1256. doi: 10.34067/KID.0000000000000223. Epub 2023 Aug 1. |
8 | 37526953 | 0 | Festa MC, Rasasingam S, Sharma A, et al. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease (CKD) Undergoing Percutaneous Coronary Intervention with a Drug Eluting Stent: A Meta-Analysis. Kidney360. 2023 Aug 1. doi: 10.34067/KID.0000000000000223. |
9 | 37059362 | 0 | Mavrakanas TA. Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation. Kidney Int. 2023 Jun;103(6):1014-1017. doi: 10.1016/j.kint.2023.03.027. Epub 2023 Apr 12. |
10 | 36514740 | 0 | Mavrakanas TA, Charytan DM. Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360. 2022 Aug 1;3(10):1769-1771. doi: 10.34067/KID.0003002022. eCollection 2022 Oct 27. |